Cyclerion Therapeutics Inc.
CYCN | NASDAQ
$23.52
$0.00 (0.00%)
Nov 2, 2026, 12:10 PM ET · Market open
TTM Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -6.71M | -5.28M | -3.53M | -2.2M | -1.95M | -2.94M | -3.06M | -5.28M | 3.01M | 2.53M | -2.89M | -5.51M | -23.58M | -35.16M | -41.19M | -47.64M | -48.43M | -51.22M | -51.65M | -60.1M | -67.62M | -70.97M |
Depreciation & Amortization | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 16.25K | 32.5K | 48.75K | 65K | 48.75K | 32.5K | 33.25K | 65K | 113K | 161K | 262K | 472K | 894K | 1.43M | 1.93M |
Stock-Based Compensation | 227K | 232K | 346K | 468K | 488K | 558K | 625K | 606K | 627K | 443K | 688K | 585K | 2.09M | 3.79M | 5.13M | 7.68M | 6.01M | 4.31M | 4.86M | 5.52M | 5.52M | 5.52M |
Other Working Capital | 274K | 814K | 99K | 236K | -655K | -204K | -537K | -1.01M | -1.43M | -2.34M | -2.93M | -5M | -3.8M | -2.4M | -4M | 813K | 2.05M | 2.15M | 988K | 286K | 1.19M | -383K |
Other Non-Cash Items | 95K | 153K | 95K | n/a | -363K | -363K | -363K | -379.25K | -12.48M | -14.5M | -14.51M | -16.26M | -3.8M | -1.79M | -1.77M | -3.56M | -1.15M | 8.4M | 8.39M | 11.91M | 10.87M | 5.51M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 1.93M | 1.37M | -227K | 356K | -1.01M | -681K | -1.54M | -1.2M | -2.64M | -5.43M | -4.6M | -5.6M | -4.47M | -864K | -2.85M | 1.22M | 3.2M | 3.35M | 1.41M | -150K | 742K | 254K |
Operating Cash Flow | -4.45M | -3.52M | -3.31M | -1.38M | -2.83M | -3.43M | -4.33M | -6.23M | -11.45M | -16.9M | -21.25M | -26.75M | -29.73M | -33.99M | -40.61M | -42.2M | -40.21M | -34.9M | -36.52M | -41.93M | -49.05M | -57.77M |
Capital Expenditures | n/a | -66K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -7K | -7K | -7K | -42K | -44K | -119K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 10.4M | 10.4M | 10.4M | 10.4M | n/a | n/a | n/a | n/a | n/a | 2K | 1.46M | 2.94M | 2.95M | 2.96M |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -66K | -66K | n/a | n/a | n/a | n/a | n/a | n/a | 10.4M | 10.4M | 10.4M | 10.4M | n/a | n/a | n/a | n/a | -7K | -5K | 1.46M | 2.89M | 2.9M | 2.84M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 3.51M |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 6K | 30.5M | 30.5M | 30.5M | 30.5M | n/a |
Financial Cash Flow | 2.9M | 2.77M | 3.32M | 3.07M | 1.25M | 1.38M | n/a | n/a | n/a | 5.02M | 5.02M | 5.04M | 5.04M | 29K | 29K | 102K | 145K | 30.76M | 30.79M | 30.86M | 55.08M | 28.12M |
Net Cash Flow | -1.62M | -816K | 8K | 1.7M | -1.58M | -2.06M | -4.34M | -6.24M | -1.05M | -1.47M | -5.81M | -11.3M | -24.68M | -33.96M | -40.58M | -42.1M | -40.07M | -304K | -434K | -4.34M | 13.93M | -25.67M |
Free Cash Flow | -4.45M | -3.59M | -3.31M | -1.38M | -2.83M | -3.43M | -4.33M | -6.23M | -11.45M | -16.9M | -21.25M | -26.75M | -29.73M | -33.99M | -40.61M | -42.2M | -40.21M | -34.9M | -36.52M | -41.97M | -49.1M | -57.88M |
Adj. Free Cash Flow | -4.68M | -3.82M | -3.66M | -1.84M | -3.32M | -3.99M | -4.96M | -6.84M | -12.08M | -17.35M | -21.93M | -27.33M | -31.82M | -37.78M | -45.74M | -49.87M | -46.23M | -39.22M | -41.38M | -47.49M | -54.62M | -63.4M |
Maintenance CapEx | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -7K | -7K | -7K | -42K | -44K | -119K |
Growth CapEx | n/a | -66K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Owner Earnings | -4.45M | -3.52M | -3.31M | -1.38M | -2.83M | -3.43M | -4.33M | -6.23M | -11.45M | -16.9M | -21.25M | -26.75M | -29.73M | -33.99M | -40.61M | -42.2M | -40.21M | -34.9M | -36.52M | -41.97M | -49.1M | -57.88M |
Add to Watchlist
Select watchlists to add or remove CYCN